OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS by Bowness, P

HLA B27 in health and disease: a double-edged sword? by Bowness, P

HLA-B27 by Bowness, P

Supplementary figures for "Inhibiting HLA-B27 homdimer-driven immune cell inflammation in Spondyloarthritis" by Bowness, P

The immunology of Ankylosing Spondylitis by Bowness, P

Anti-tumour necrosis factor therapy in seronegative spondyloarthritis. by Catherine, S, Bowness, P

The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis. by Kollnberger, S, Bowness, P

New developments in our understanding of Ankylosing Spondylitis pathogenesis by Voruganti, A, Bowness, P

MHC class I multimers. by Sun, M, Bowness, P

Recognition of antigen and superantigen by cytotoxic lymphocytes by Bowness, P, Bowness, Paul

IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27 by Bowness, P, Mcmichael, A

T-cell receptors and rheumatic disease: approaches to repertoire analysis. by Bowness, P, Bell, J

Factors affecting TCR-repertoire diversity. by Wedderburn, L, Bowness, P

HLA-B27: natural function and pathogenic role in spondyloarthritis. by McMichael, A, Bowness, P

MHC molecules lead many lives. Workshop on MHC Class I Molecules at the interface between Biology and Medicine. by Bowness, P, Caplan, S, Edidin, M

The link between HLA-B27 and SpA--new ideas on an old problem. by McHugh, K, Bowness, P

HLA B27 can form heavy chain homodimers in vivo and in vivo, possible role of cys 67. by Bowness, P, Allen, R, Mcmichael, A

The nucleotide sequence of HLA-B*2704 reveals a new amino acid substitution in exon 4 which is also present in HLA-B*2706. by Rudwaleit, M, Bowness, P, Wordsworth, P

Two birds with one stone: doing metabolomics with your proteomics kit. by Fischer, R, Bowness, P, Kessler, B

A proteomic approach to the identification of marker proteins for ankylosing spondylitis and rheumatoid arthritis by Wright, C, Kessler, B, Bowness, P